Effect of reperfusion and hyperemia on the myocardial distribution of technetium-99m t-butylisonitrile
- PMID: 3755164
Effect of reperfusion and hyperemia on the myocardial distribution of technetium-99m t-butylisonitrile
Abstract
Technetium-99m t-butylisonitrile ([99mTc]TBI) is a promising new radiotracer for myocardial imaging. Its myocardial uptake is sufficiently high in humans to permit planar, tomographic, and gated images of excellent technical quality. We studied the behavior of [99mTc]TBI in the dog at rest and under conditions of hyperemia and reperfusion in order to determine the relationship between [99mTc]TBI myocardial concentration and blood flow. After permanent occlusion of the left anterior descending artery, the correlation between the relative myocardial concentration of [99mTc]TBI and regional myocardial blood flow (RMBF) measured with radiolabeled microspheres was excellent. In a dog model of transient hyperemia, the concentration of [99mTc]TBI was directly related to blood flow but underestimated the degree of hyperemia. Technetium-99m TBI redistributed into transiently ischemic myocardium. The myocardial concentrations of [99mTc]TBI and thallium-201(201TI) in transiently ischemic myocardium were similar at 10 and 30 min following reperfusion and were significantly higher than blood flow prior to reperfusion. When [99mTc]TBI was injected into the left anterior descending artery, the washout was slow, falling to 78% of initial activity at 120 min after injection. In conclusion, [99mTc]TBI reflects regional myocardial blood flow accurately in ischemic and normal resting myocardium and underestimates blood flow at high flows. The rate of myocardial redistribution after reperfusion is similar for [99mTc]TBI and 201TI.
Similar articles
-
A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the human.J Nucl Med. 1984 Dec;25(12):1350-5. J Nucl Med. 1984. PMID: 6334145
-
Cardiac imaging and myocardial kinetics of technetium-tertiary butyl-isonitrile during dipyridamole-induced hyperemia.Am Heart J. 1988 Oct;116(4):979-88. doi: 10.1016/0002-8703(88)90148-2. Am Heart J. 1988. PMID: 3177197
-
Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile.Circulation. 1990 Oct;82(4):1424-37. doi: 10.1161/01.cir.82.4.1424. Circulation. 1990. PMID: 2401074
-
Physiological basis of myocardial perfusion imaging with the technetium 99m agents.Semin Nucl Med. 1991 Jul;21(3):173-81. doi: 10.1016/s0001-2998(05)80038-8. Semin Nucl Med. 1991. PMID: 1835136 Review.
-
Experimental studies of the physiologic properties of technetium-99m isonitriles.Am J Cardiol. 1990 Oct 16;66(13):5E-8E. doi: 10.1016/0002-9149(90)90605-z. Am J Cardiol. 1990. PMID: 2145747 Review.
Cited by
-
Kinetics of Tc-99m hexakis t-butyl isonitrile in normal and ischemic canine myocardium.Eur J Nucl Med. 1989;15(6):287-91. doi: 10.1007/BF00435467. Eur J Nucl Med. 1989. PMID: 2767078
-
Myocardial scintigraphy--25 years after start.Eur J Nucl Med. 1988;13(12):619-36. doi: 10.1007/BF00256390. Eur J Nucl Med. 1988. PMID: 3282885 Review.
-
99mTc-MIBI (RP-30) to define the extent of myocardial ischemia and evaluate ventricular function.Eur J Nucl Med. 1990;16(4-6):223-30. doi: 10.1007/BF00842772. Eur J Nucl Med. 1990. PMID: 2351170
-
Myocardial perfusion imaging after transient balloon occlusion during percutaneous coronary interventions.J Nucl Cardiol. 2007 Apr;14(2):221-8. doi: 10.1016/j.nuclcard.2006.11.012. J Nucl Cardiol. 2007. PMID: 17386385 Clinical Trial.
-
The utilization of Tc-99m-TBI as a myocardial perfusion agent in exercise studies: comparison with Tl-201 thallous chloride and examination of its biodistribution in humans.Eur J Nucl Med. 1986;12(7):333-6. doi: 10.1007/BF00263814. Eur J Nucl Med. 1986. PMID: 3079539
MeSH terms
Substances
LinkOut - more resources
Full Text Sources